Table of Contents
1. Introduction to lung cancer2. Environmental toxicants
3. Environmental toxicants and lung cancer
4. Chemical substances linked to lung cancer
5. Asbestos and lung cancer
6. Arsenic and lung cancer
7. Benzene and lung cancer
8. Cadmium and lung cancer
9. Nickel and lung cancer
10. Uranium and lung cancer
11. Formaldehyde and lung cancer
12. Carbon tetrachloride and lung cancer
13. Industrial emissions and pollutants linked to lung cancer
14. Ionizing and non-ionizing radiation linked to lung cancer
15. Household smoke and secondhand smoke linked to lung cancer
16. Prevention Strategies for lung cancer
Authors
Kamal Dua Senior Lecturer, Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Sydney, NSW, Australia.Dr. Kamal Dua is a Senior Lecturer in the Discipline of Pharmacy at the Graduate School of Health, University of Technology Sydney (UTS), Australia. He has research experience of over many years in the field of drug delivery systems targeting inflammatory diseases. Dr. Dua researches in two complementary areas; drug delivery and immunology, specifically addressing how these disciplines can advance one another, helping the community to live longer and healthier. This is evidenced by his extensive publication record in reputed journals. Dr. Dua's research interests focus on harnessing the pharmaceutical potential of modulating critical regulators such as Interleukins and microRNAs and developing new and effective drug delivery formulations for the management of chronic airway diseases. He has published more than 80 research articles in peer-reviewed international journals and authored or co-authored four books. He is an active member of many national and international professional societies.
Gaurav Gupta Associate Professor, Suresh Gyan Vihar University, Jaipur, Rajasthan, India. Dr. Gaurav Gupta holds a doctoral degree from Pacific University, Udaipur, Rajasthan, India. He has more than nine years of experience in molecular and biochemical pharmacology including phytochemistry, respiratory diseases, psychopharmacology, and cancer biology by employing experimental animal models to understand the cellular and molecular mechanism. Dr Gupta is dedicated to improving outcomes in healthcare through my initiatives in pharmacology and phytochemistry research and effective teaching in the field of Pharmaceutical Sciences. Dr Gupta is currently associated as an Associate Professor with Suresh Gyan Vihar University, Jaipur, Rajasthan, India. Dr Gupta has >300 research and review articles in national and international journals of repute. The total cumulative Impact Factor of his published papers is around 2000. Ronan MacLoughlin Aerogen pty Ltd, Ireland. Dr Ronan MacLoughlin is Director R&D, Science & Emerging Technologies, at Aerogen, an Irish medical device company specialising in Respiratory Drug Delivery. He is a former head of Medical Affairs, with responsibility for >45 investigator-initiated trials. With more than 20 years' experience in the design anddevelopment of drug delivery systems and drug device combinations, he has >220 collaborative publications,
as well as 12 granted patents.
His most recent focus has been on enabling several clinical programs making use of aerosolised prophylactics
and therapeutics for COVID-19, and his work on delivery of inhaled vaccines has resulted in the
world's first approval for an orally inhaled vaccine for COVID-19 (Convidecia Air). His contribution to the
state of the art in fugitive medical and patient-derived aerosols was central to the evolution of several
critical care consensus statements around the safe use of aerosol therapy during the COVID-19 pandemic. Sachin Kumar Singh Professor and head of Pharmaceutical Chemistry and Pharmaceutical Analysis, School of Pharmaceutical Sciences, Lovely Professional University, India.
Dr. Sachin Kumar Singh, is working as professor and head of Pharmaceutical Chemistry and Pharmaceutical Analysis at School of Pharmaceutical Sciences, Lovely Professional University, India and visiting professor Australian Research Centre in Complementary and Integrative Medicine (ARCCIM), School of Public Health, Faculty of Health, University of Technology Sydney, Australia. He has many years of teaching and research experience. Dr. Singh has published more than 350 research papers with cumulative impact of 1300, authored several books, and dozens of book chapters. He is also featured under top 2% scientists of world as per the list of 2021, published by Stanford University, USA.
Asif Ahmad Bhat Suresh Gyan University, Kolkata, India. Asif Ahmad Bhat graduated from Rajasthan university of health sciences, Jaipur, and post graduated from Jamia Hamdard, Delhi. He is currently pursuing PhD from Jadavpur University, Kolkata. He has acquired substantial expertise in nano drug delivery systems and have hands-on experience with animal experimentation for various biological studies. He has published more than 25 research and review papers in international and national journals. He has authored three books for students of pharmaceutical sciences. He is currently associated as an Assistant Professor with Suresh Gyan Vihar University, Jaipur, Rajasthan, India.